Alain Hendlisz

9PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersOther psychology not elsewhere classifiedImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 30, 2025
Development and Validation of an 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Zelda Paquier, Jennifer Dhont, Thomas Guiot

|Apr 13, 2024
Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study.

Ayoub Mokhtari, Roberto Casale, Zohaib Salahuddin

|Dec 23, 2023
Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer.

Irene Assaf, Danai Fimereli, Geraldine Anthoine

|Jan 13, 2022
JCOG0603: Are We Really Sure This Was a Negative Trial?

Rita Saude Conde, Giacomo Bregni, Everardo Saad

|Oct 12, 2021
First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study.

Heinz-Josef Lenz, Eric Van Cutsem, Maria Luisa Limon

|May 31, 2021
Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.

Amélie Deleporte, Marc Van den Eynde, Frédéric Forget

Pageof 2

Frequent Collaborators

3 joint publications

Francesco Sclafani

2 joint publications

Thomas Guiot

2 joint publications

Vincent Donckier

2 joint publications

Zelda Paquier